Clinical Trial Update: Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on pregnancy outcomes in women with unexplained recurrent pregnancy loss treated with low dose aspirin and unfractionated heparin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• Low-dose aspirin (acetylsalicylic acid)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Benha University | Conditions: Recurrent Pregnancy Loss | Phase 3 | Status: UNKNOWN